-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on HealthEquity, Lowers Price Target to $110

Benzinga·02/18/2026 15:37:44
Listen to the news
Barclays analyst Glen Santangelo maintains HealthEquity (NASDAQ:HQY) with a Overweight and lowers the price target from $118 to $110.